Fuscaxanthone C
- CAS NO.:15404-76-9
- Empirical Formula: C26H30O6
- Molecular Weight: 438.51
- MDL number: MFCD28350931
- SAFETY DATA SHEET (SDS)
- Update Date: 2026-07-16 07:06:08
What is Fuscaxanthone C?
The Uses of Fuscaxanthone C
Dimethylmangostin is a xanthone obtained from Garcinia mangostana and is used in the semisynthetic preparation of various biologically active derivatives.
Definition
ChEBI: 1-Hydroxy-3,6,7-trimethoxy-2,8-diprenylxanthone is a member of xanthones.
Properties of Fuscaxanthone C
| Melting point: | 119-122℃ (ligroine acetone ) |
| Boiling point: | 601.5±55.0 °C(Predicted) |
| Density | 1.167±0.06 g/cm3(Predicted) |
| pka | 6.98±0.20(Predicted) |
| form | Solid |
| color | White to light yellow |
Safety information for Fuscaxanthone C
Computed Descriptors for Fuscaxanthone C
New Products
2-(2-Chlorophenyl)glycine Propiolic Acid 1-(3-Hydroxy-4-methoxyphenyl)-2-nitroethene (±)-amino(2-fluorophenyl)acetic acid trans-3-Benzyloxy-4-methoxy-beta-nitrostyrene 1-Pentadecanol 4-(4-Αminophenyl)-3-Morpholinone 3-Morpholino-1-(4-(2-oxopiperidin-1-yl) phenyl)-5,6-dihyropyridin-2-(1H)-one 1-(4-Aminophenyl)-3-morpholino-5,6-dihydropyridin-2(1H)-one N-cyanoacetylurethane 1H-IndazoleRelated products of tetrahydrofuran







You may like
-
40216-83-9 trans-4-Hydroxy-L-proline methyl ester hydrochloride 98+View Details
40216-83-9 -
471-25-0 Propiolic Acid 98+View Details
471-25-0 -
84145-28-8 98+View Details
84145-28-8 -
trans-3-Benzyloxy-4-methoxy-beta-nitrostyrene 98+View Details
63909-29-5 -
2-(2-Chlorophenyl)glycine 88744-36-9 98+View Details
88744-36-9 -
40216-83-9 trans-4-Hydroxy-L-proline methyl ester hydrochloride 98+View Details
40216-83-9 -
629-76-5 98+View Details
629-76-5 -
1-(3-Hydroxy-4-methoxyphenyl)-2-nitroethene 98+View Details
39816-35-8
Statement: All products displayed on this website are only used for non medical purposes such as industrial applications or scientific research, and cannot be used for clinical diagnosis or treatment of humans or animals. They are not medicinal or edible.
